[1] MENON V， GREENE T， WANG X，et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease[J] .Kidney Int， 2005，68(2)： 766-772. [2] ISEKI K， MIYASATO F， TOKUYAMA K， et al. Low diastolic blood pressure， hypoalbuminemia， and risk of death in a cohort of chronic hemodialysis patients [J] .Kidney Int，1997，51(4)： 1212-1217. [3] GOLUB R， SORRENTO J J， CANTU R， et al. Efficacy of albumin supplementation in the surgical intensive care unit： a prospective randomized study [J] . Crit Care Med，1994，22(4)： 613-619. [4] RUBIN H， CARLSON S， DEMEO M， et al. Randomized， double-blind study of intravenous human albumin in hypoalbuminemic patients receiving total parenteral nutrition [J] .Crit Care Med，1997，25(2)：249-252. [5] FOLEY E F， BORLASE B C， DZIK W H， et al. Albumin supplementation in the critically ill. A prospective， randomized trial[J] .Arch Surg，1990，125(6)： 739-742. [6] MBABA MENA J， DE BACKER D， VINCENT J L. Effects of a hydrox-yethylstarch solution on plasma colloid osmotic pressure in acutely ill patients [J] .Acta Anaesthesiol Belg，2000，51：39-42. [7] FINFER S， BELLOMO R， BOYCE N，et al.A comparison of albumin and saline for fluid resuscitation in the intensive care unit[J] .N Engl J Med， 2004，350(22)：2247-2256. [8] COCHRANE INJURIES GROUP ALBUMIN REVIEWERS. Human albumin administration in critically ill patients： systematic review of randomized controlled trials [J] .BMJ，1998，317(7153)：235-240. [9] THE ALBUMIN REVIEWERS (ALDERSON P， BUNN F， LEFEBVRE C，et al). Human albumin solution for resuscitation and volume expansion in critically ill patients (Cochrane Review) [EB-OL] . In： The Cochrane Library， Issue 1， 2006. Chichester， UK： John Wiley & Sons， Ltd. [10] WILKES M M， NAVICKIS R J. Patient survival after human albumin administration： A meta-analysis of randomized， controlled trials [J] .Ann Intern Med，2001，135(3)：149-164. [11] ALDERSON P， SCHIERHOUT G， ROBERTS I， et al. Colloids versus crystalloids for fluid resuscitation in critically ill patients (Cochrane Review) [EB-OL] .In： The Cochrane Library， Issue 2， 2003. Oxford： Update Software [12] BUNN F， ALDERSON P， HAWKINS V. Colloid solutions for fluid resuscitation (Cochrane Review) [EB-OL] . In： The Cochrane Library， Issue 1， 2006. Chichester， UK： John Wiley & Sons， Ltd. [13] HAYNES G R， NAVICKIS R J， WILKES M M， et al. Albumin administration： what is the evidence of clinical benefit? A systematic review of randomized controlled trials[J] .Eur J Anaesthesiol，2003，20(10)：771-779. [14] VINCENT J L， NAVICKIS R J， WILKES M M. Morbidity in hospitalized patients receiving human albumin： A meta-analysis of randomized， controlled trials [J] .Crit Care Med，2004，32(10)：2029-2038. [15] ZAVRAKIDIS N. Intravenous fluids for abdominal aortic surgery (Cochrane Review) [EB-OL] . In： The Cochrane Library， Issue 1， 2006. Chichester， UK： John Wiley & Sons， Ltd. [16] ASPLUND K. Haemodilution for acute ischaemic stroke (Cochrane Review) [EB-OL] . In： The Cochrane Library， Issue 1， 2006. Chichester， UK：John Wiley & Sons， Ltd. [17] OSBORN D A， EVANS N. Early volume expansion for prevention of morbidity and mortality in very preterm infants (Cochrane Review) [EB-OL] . In： The Cochrane Library， Issue 1， 2006. Chichester，UK： John Wiley & Sons， Ltd. [18] JARDINE L A， JENKINS-MANNING S， DAVIES M W.Albumin infusion for low serum albumin in preterm newborn infants (Cochrane Review) [EB-OL] . In： The Cochrane Library， Issue 1， 2006. Chichester， UK： John Wiley & Sons， Ltd. [19] ABOULGHAR M， EVERS J H， AL-INANY H. Intra-venous albumin for preventing severe ovarian hyperstimulation syndrome (Cochrane Review) [EB-OL] . In： The Cochrane Library， Issue 1， 2006. Chichester， UK： John Wiley & Sons， Ltd. [20] BELLVER J， MUNOZ E A， BALLESTEROS A， et al. Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients： a randomized controlled study [J] .Hum Reprod， 2003，18(11)： 2283-2288.